ID   LDHA_HUMAN              Reviewed;         332 AA.
AC   P00338; B4DKQ2; B7Z5E3; D3DQY3; F8W819; Q53G53; Q6IBM7; Q6ZNV1;
AC   Q9UDE8; Q9UDE9;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   10-MAY-2017, entry version 209.
DE   RecName: Full=L-lactate dehydrogenase A chain;
DE            Short=LDH-A;
DE            EC=1.1.1.27;
DE   AltName: Full=Cell proliferation-inducing gene 19 protein;
DE   AltName: Full=LDH muscle subunit;
DE            Short=LDH-M;
DE   AltName: Full=Renal carcinoma antigen NY-REN-59;
GN   Name=LDHA; ORFNames=PIG19;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3838278; DOI=10.1111/j.1432-1033.1985.tb08711.x;
RA   Tsujibo H., Tiano H.F., Li S.S.-L.;
RT   "Nucleotide sequences of the cDNA and an intronless pseudogene for
RT   human lactate dehydrogenase-A isozyme.";
RL   Eur. J. Biochem. 147:9-15(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=3000353; DOI=10.1042/bj2310537;
RA   Chung F.Z., Tsujibo H., Bhattacharyya U., Sharief F.S., Li S.S.-L.;
RT   "Genomic organization of human lactate dehydrogenase-A gene.";
RL   Biochem. J. 231:537-541(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kim J.W.;
RT   "Identification of a human proliferation-inducing gene.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 4).
RC   TISSUE=Umbilical cord;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   GLU-222.
RC   TISSUE=Gastric carcinoma;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-14; 43-57; 60-73; 77-112; 133-149; 158-169;
RP   233-243; 306-315 AND 319-328, CLEAVAGE OF INITIATOR METHIONINE,
RP   ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAR-2005) to UniProtKB.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 112-121 AND 160-175.
RX   PubMed=1953713; DOI=10.1016/S0006-291X(05)81177-5;
RA   Maekawa M., Sudo K., Li S.S., Kanno T.;
RT   "Analysis of genetic mutations in human lactate dehydrogenase-A(M)
RT   deficiency using DNA conformation polymorphism in combination with
RT   polyacrylamide gradient gel and silver staining.";
RL   Biochem. Biophys. Res. Commun. 180:1083-1090(1991).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 250-254.
RX   PubMed=1959923; DOI=10.1007/BF00204925;
RA   Maekawa M., Sudo K., Li S.S., Kanno T.;
RT   "Genotypic analysis of families with lactate dehydrogenase A (M)
RT   deficiency by selective DNA amplification.";
RL   Hum. Genet. 88:34-38(1991).
RN   [13]
RP   INVOLVEMENT IN GSD11.
RX   PubMed=2334430; DOI=10.1016/0006-291X(90)92374-9;
RA   Maekawa M., Sudo K., Kanno T., Li S.S.;
RT   "Molecular characterization of genetic mutation in human lactate
RT   dehydrogenase-A (M) deficiency.";
RL   Biochem. Biophys. Res. Commun. 168:677-682(1990).
RN   [14]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(SICI)1097-0215(19991112)83:4<456::AID-IJC4>3.0.CO;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-
RT   cell carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [15]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-10, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-5; LYS-14; LYS-57; LYS-81;
RP   LYS-118; LYS-126 AND LYS-318, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S.,
RA   Fischer-Posovszky P., Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion
RT   profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [22]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18 AND SER-310, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH NADH AND
RP   SUBSTRATE ANALOG, AND HOMOTETRAMERIZATION.
RX   PubMed=11276087;
RX   DOI=10.1002/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#;
RA   Read J.A., Winter V.J., Eszes C.M., Sessions R.B., Brady R.L.;
RT   "Structural basis for altered activity of M- and H-isozyme forms of
RT   human lactate dehydrogenase.";
RL   Proteins 43:175-185(2001).
RN   [27]
RP   VARIANT CYS-315.
RX   PubMed=1445373;
RA   Sudo K., Maekawa M., Shioya M., Ikeda K., Takahashi N., Isogai Y.,
RA   Li S.S.-L., Kanno T., Machida K., Toriumi J.;
RT   "Molecular analysis of genetic mutation in electrophoretic variant of
RT   human lactate dehydrogenase-A(M) subunit.";
RL   Biochem. Int. 27:1051-1057(1992).
RN   [28]
RP   VARIANT GLU-222.
RX   PubMed=7908613;
RA   Maekawa M., Sudo K., Kobayashi A., Sugiyama E., Li S.S.-L., Kanno T.;
RT   "Fast-type electrophoretic variant of lactate dehydrogenase M(A) and
RT   comparison with other missense mutations in lactate dehydrogenase M(A)
RT   and H(B) genes.";
RL   Clin. Chem. 40:665-668(1994).
CC   -!- CATALYTIC ACTIVITY: (S)-lactate + NAD(+) = pyruvate + NADH.
CC   -!- PATHWAY: Fermentation; pyruvate fermentation to lactate; (S)-
CC       lactate from pyruvate: step 1/1.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:11276087}.
CC   -!- INTERACTION:
CC       P11142:HSPA8; NbExp=4; IntAct=EBI-372327, EBI-351896;
CC       P07195:LDHB; NbExp=8; IntAct=EBI-10195200, EBI-358748;
CC       Q499Y8:MAPK10; NbExp=5; IntAct=EBI-10195200, EBI-10241715;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P00338-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P00338-2; Sequence=VSP_014261, VSP_042787;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P00338-3; Sequence=VSP_042206;
CC       Name=4;
CC         IsoId=P00338-4; Sequence=VSP_042786;
CC       Name=5;
CC         IsoId=P00338-5; Sequence=VSP_042788, VSP_042789;
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- DISEASE: Glycogen storage disease 11 (GSD11) [MIM:612933]: A
CC       metabolic disorder that results in exertional myoglobinuria, pain,
CC       cramps and easy fatigue. {ECO:0000269|PubMed:2334430}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the LDH/MDH superfamily. LDH family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Lactate dehydrogenase entry;
CC       URL="https://en.wikipedia.org/wiki/Lactate_dehydrogenase";
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Another dark horse -
CC       Issue 109 of September 2009;
CC       URL="http://web.expasy.org/spotlight/back_issues/109";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X02152; CAA26088.1; -; mRNA.
DR   EMBL; X03077; CAA26879.1; -; Genomic_DNA.
DR   EMBL; X03078; CAA26879.1; JOINED; Genomic_DNA.
DR   EMBL; X03079; CAA26879.1; JOINED; Genomic_DNA.
DR   EMBL; X03080; CAA26879.1; JOINED; Genomic_DNA.
DR   EMBL; X03081; CAA26879.1; JOINED; Genomic_DNA.
DR   EMBL; X03082; CAA26879.1; JOINED; Genomic_DNA.
DR   EMBL; X03083; CAA26879.1; JOINED; Genomic_DNA.
DR   EMBL; AY423727; AAS00490.1; -; mRNA.
DR   EMBL; AK130587; BAC85389.1; -; mRNA.
DR   EMBL; AK296667; BAG59264.1; -; mRNA.
DR   EMBL; AK298834; BAH12879.1; -; mRNA.
DR   EMBL; CR456775; CAG33056.1; -; mRNA.
DR   EMBL; CR541714; CAG46515.1; -; mRNA.
DR   EMBL; AK223078; BAD96798.1; -; mRNA.
DR   EMBL; AC084117; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68395.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68396.1; -; Genomic_DNA.
DR   EMBL; BC067223; AAH67223.1; -; mRNA.
DR   EMBL; S66853; AAB20418.1; -; Genomic_DNA.
DR   CCDS; CCDS44549.1; -. [P00338-4]
DR   CCDS; CCDS53609.1; -. [P00338-3]
DR   CCDS; CCDS53610.1; -. [P00338-2]
DR   CCDS; CCDS53611.1; -. [P00338-5]
DR   CCDS; CCDS7839.1; -. [P00338-1]
DR   PIR; A00347; DEHULM.
DR   RefSeq; NP_001128711.1; NM_001135239.1. [P00338-4]
DR   RefSeq; NP_001158886.1; NM_001165414.1. [P00338-3]
DR   RefSeq; NP_001158887.1; NM_001165415.1. [P00338-2]
DR   RefSeq; NP_001158888.1; NM_001165416.1. [P00338-5]
DR   RefSeq; NP_005557.1; NM_005566.3. [P00338-1]
DR   UniGene; Hs.2795; -.
DR   PDB; 1I10; X-ray; 2.30 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 4AJP; X-ray; 2.38 A; A/B/C/D=2-332.
DR   PDB; 4JNK; X-ray; 1.90 A; A/B/C/D=2-332.
DR   PDB; 4L4R; X-ray; 2.10 A; A/H=2-332.
DR   PDB; 4L4S; X-ray; 2.90 A; A/H=2-332.
DR   PDB; 4M49; X-ray; 2.05 A; A/B/C/D=2-332.
DR   PDB; 4OJN; X-ray; 2.40 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 4OKN; X-ray; 2.10 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 4QO7; X-ray; 2.14 A; A/B/C/D=2-332.
DR   PDB; 4QO8; X-ray; 2.00 A; A/B/C/D=2-332.
DR   PDB; 4QSM; X-ray; 3.00 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 4QT0; X-ray; 3.20 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 4R68; X-ray; 2.11 A; A/B/C/D=2-332.
DR   PDB; 4R69; X-ray; 3.19 A; A/B/C/D=2-332.
DR   PDB; 4RLS; X-ray; 1.91 A; A/B/C/D=2-332.
DR   PDB; 4ZVV; X-ray; 2.20 A; A/B/C/D=1-332.
DR   PDB; 5IXS; X-ray; 2.05 A; A/B/C/D=2-332.
DR   PDB; 5IXY; X-ray; 3.00 A; A/B/C/D=2-332.
DR   PDBsum; 1I10; -.
DR   PDBsum; 4AJP; -.
DR   PDBsum; 4JNK; -.
DR   PDBsum; 4L4R; -.
DR   PDBsum; 4L4S; -.
DR   PDBsum; 4M49; -.
DR   PDBsum; 4OJN; -.
DR   PDBsum; 4OKN; -.
DR   PDBsum; 4QO7; -.
DR   PDBsum; 4QO8; -.
DR   PDBsum; 4QSM; -.
DR   PDBsum; 4QT0; -.
DR   PDBsum; 4R68; -.
DR   PDBsum; 4R69; -.
DR   PDBsum; 4RLS; -.
DR   PDBsum; 4ZVV; -.
DR   PDBsum; 5IXS; -.
DR   PDBsum; 5IXY; -.
DR   ProteinModelPortal; P00338; -.
DR   SMR; P00338; -.
DR   BioGrid; 110131; 143.
DR   IntAct; P00338; 33.
DR   MINT; MINT-4998672; -.
DR   STRING; 9606.ENSP00000445175; -.
DR   BindingDB; P00338; -.
DR   ChEMBL; CHEMBL4835; -.
DR   DrugBank; DB02483; Etheno-Nad.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB02701; Nicotinamide.
DR   DrugBank; DB03940; Oxamic Acid.
DR   iPTMnet; P00338; -.
DR   PhosphoSitePlus; P00338; -.
DR   SwissPalm; P00338; -.
DR   BioMuta; LDHA; -.
DR   DMDM; 126047; -.
DR   DOSAC-COBS-2DPAGE; P00338; -.
DR   OGP; P00338; -.
DR   REPRODUCTION-2DPAGE; IPI00217966; -.
DR   EPD; P00338; -.
DR   PaxDb; P00338; -.
DR   PeptideAtlas; P00338; -.
DR   PRIDE; P00338; -.
DR   TopDownProteomics; P00338-1; -. [P00338-1]
DR   TopDownProteomics; P00338-4; -. [P00338-4]
DR   TopDownProteomics; P00338-5; -. [P00338-5]
DR   DNASU; 3939; -.
DR   Ensembl; ENST00000227157; ENSP00000227157; ENSG00000134333. [P00338-5]
DR   Ensembl; ENST00000379412; ENSP00000368722; ENSG00000134333. [P00338-1]
DR   Ensembl; ENST00000396222; ENSP00000379524; ENSG00000134333. [P00338-2]
DR   Ensembl; ENST00000422447; ENSP00000395337; ENSG00000134333. [P00338-1]
DR   Ensembl; ENST00000430553; ENSP00000406172; ENSG00000134333. [P00338-4]
DR   Ensembl; ENST00000540430; ENSP00000445175; ENSG00000134333. [P00338-3]
DR   Ensembl; ENST00000542179; ENSP00000445331; ENSG00000134333. [P00338-1]
DR   GeneID; 3939; -.
DR   KEGG; hsa:3939; -.
DR   UCSC; uc001mol.4; human. [P00338-1]
DR   CTD; 3939; -.
DR   DisGeNET; 3939; -.
DR   GeneCards; LDHA; -.
DR   HGNC; HGNC:6535; LDHA.
DR   HPA; CAB015336; -.
DR   MalaCards; LDHA; -.
DR   MIM; 150000; gene.
DR   MIM; 612933; phenotype.
DR   neXtProt; NX_P00338; -.
DR   OpenTargets; ENSG00000134333; -.
DR   Orphanet; 284426; Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency.
DR   PharmGKB; PA30319; -.
DR   eggNOG; KOG1495; Eukaryota.
DR   eggNOG; COG0039; LUCA.
DR   GeneTree; ENSGT00550000074541; -.
DR   HOGENOM; HOG000213793; -.
DR   HOVERGEN; HBG000462; -.
DR   InParanoid; P00338; -.
DR   KO; K00016; -.
DR   OMA; NNEHRVL; -.
DR   OrthoDB; EOG091G0HME; -.
DR   PhylomeDB; P00338; -.
DR   TreeFam; TF314963; -.
DR   Reactome; R-HSA-70268; Pyruvate metabolism.
DR   SABIO-RK; P00338; -.
DR   SIGNOR; P00338; -.
DR   UniPathway; UPA00554; UER00611.
DR   ChiTaRS; LDHA; human.
DR   EvolutionaryTrace; P00338; -.
DR   GeneWiki; LDHA; -.
DR   GenomeRNAi; 3939; -.
DR   PRO; PR:P00338; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000134333; -.
DR   CleanEx; HS_LDHA; -.
DR   ExpressionAtlas; P00338; baseline and differential.
DR   Genevisible; P00338; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0019900; F:kinase binding; IEA:Ensembl.
DR   GO; GO:0004459; F:L-lactate dehydrogenase activity; EXP:Reactome.
DR   GO; GO:0051287; F:NAD binding; IEA:Ensembl.
DR   GO; GO:0006096; P:glycolytic process; NAS:UniProtKB.
DR   GO; GO:0006089; P:lactate metabolic process; IEA:Ensembl.
DR   GO; GO:0019674; P:NAD metabolic process; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0048569; P:post-embryonic animal organ development; IEA:Ensembl.
DR   GO; GO:0006090; P:pyruvate metabolic process; TAS:Reactome.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0043627; P:response to estrogen; IEA:Ensembl.
DR   GO; GO:0009749; P:response to glucose; IEA:Ensembl.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   GO; GO:0021762; P:substantia nigra development; IEP:UniProtKB.
DR   HAMAP; MF_00488; Lactate_dehydrog; 1.
DR   InterPro; IPR001557; L-lactate/malate_DH.
DR   InterPro; IPR011304; L-lactate_DH.
DR   InterPro; IPR018177; L-lactate_DH_AS.
DR   InterPro; IPR022383; Lactate/malate_DH_C.
DR   InterPro; IPR001236; Lactate/malate_DH_N.
DR   InterPro; IPR015955; Lactate_DH/Glyco_Ohase_4_C.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   Pfam; PF02866; Ldh_1_C; 1.
DR   Pfam; PF00056; Ldh_1_N; 1.
DR   PIRSF; PIRSF000102; Lac_mal_DH; 1.
DR   PRINTS; PR00086; LLDHDRGNASE.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF56327; SSF56327; 1.
DR   TIGRFAMs; TIGR01771; L-LDH-NAD; 1.
DR   PROSITE; PS00064; L_LDH; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Disease mutation;
KW   Glycogen storage disease; NAD; Oxidoreductase; Phosphoprotein;
KW   Polymorphism; Reference proteome; Ubl conjugation.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.10}.
FT   CHAIN         2    332       L-lactate dehydrogenase A chain.
FT                                /FTId=PRO_0000168411.
FT   NP_BIND      29     57       NAD. {ECO:0000269|PubMed:11276087}.
FT   ACT_SITE    193    193       Proton acceptor.
FT   BINDING      99     99       NAD. {ECO:0000269|PubMed:11276087}.
FT   BINDING     106    106       Substrate.
FT   BINDING     138    138       NAD or substrate.
FT                                {ECO:0000269|PubMed:11276087}.
FT   BINDING     169    169       Substrate.
FT   BINDING     248    248       Substrate.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:19413330,
FT                                ECO:0000244|PubMed:22223895,
FT                                ECO:0000269|Ref.10}.
FT   MOD_RES       5      5       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES       5      5       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P06151}.
FT   MOD_RES      10     10       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      14     14       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      18     18       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES      57     57       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      81     81       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     118    118       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     118    118       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P06151}.
FT   MOD_RES     126    126       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     224    224       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P06151}.
FT   MOD_RES     232    232       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P06151}.
FT   MOD_RES     239    239       Phosphotyrosine.
FT                                {ECO:0000250|UniProtKB:P06151}.
FT   MOD_RES     243    243       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P06151}.
FT   MOD_RES     309    309       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P04642}.
FT   MOD_RES     310    310       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     318    318       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     318    318       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P06151}.
FT   MOD_RES     322    322       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P04642}.
FT   VAR_SEQ       1      1       M -> MGEPSGGYTYTQTSIFLFHAKIPFGSKSNM (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042206.
FT   VAR_SEQ      82    139       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042786.
FT   VAR_SEQ     230    274       VHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRV
FT                                HPVS -> CRYTLGDPKGAAILKSSDVISFHCLGYNRILGG
FT                                GCACCPFYLICD (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_014261.
FT   VAR_SEQ     237    241       SAYEV -> RVFTE (in isoform 5).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_042788.
FT   VAR_SEQ     242    332       Missing (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_042789.
FT   VAR_SEQ     275    332       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_042787.
FT   VARIANT     161    161       S -> R (in dbSNP:rs5030621).
FT                                /FTId=VAR_059374.
FT   VARIANT     222    222       K -> E (in dbSNP:rs748436361).
FT                                {ECO:0000269|PubMed:7908613,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_004180.
FT   VARIANT     315    315       R -> C (in dbSNP:rs200093825).
FT                                {ECO:0000269|PubMed:1445373}.
FT                                /FTId=VAR_004181.
FT   HELIX         4      8       {ECO:0000244|PDB:4JNK}.
FT   STRAND        9     12       {ECO:0000244|PDB:4JNK}.
FT   STRAND       20     26       {ECO:0000244|PDB:4JNK}.
FT   HELIX        30     41       {ECO:0000244|PDB:4JNK}.
FT   STRAND       46     51       {ECO:0000244|PDB:4JNK}.
FT   HELIX        55     67       {ECO:0000244|PDB:4JNK}.
FT   HELIX        68     71       {ECO:0000244|PDB:4JNK}.
FT   STRAND       77     79       {ECO:0000244|PDB:4JNK}.
FT   HELIX        83     86       {ECO:0000244|PDB:4JNK}.
FT   STRAND       90     94       {ECO:0000244|PDB:4JNK}.
FT   HELIX       107    127       {ECO:0000244|PDB:4JNK}.
FT   STRAND      132    135       {ECO:0000244|PDB:4JNK}.
FT   STRAND      137    139       {ECO:0000244|PDB:4JNK}.
FT   HELIX       140    151       {ECO:0000244|PDB:4JNK}.
FT   HELIX       155    157       {ECO:0000244|PDB:4JNK}.
FT   STRAND      158    160       {ECO:0000244|PDB:4JNK}.
FT   HELIX       164    178       {ECO:0000244|PDB:4JNK}.
FT   HELIX       182    184       {ECO:0000244|PDB:4JNK}.
FT   STRAND      189    193       {ECO:0000244|PDB:4JNK}.
FT   HELIX       194    196       {ECO:0000244|PDB:4JNK}.
FT   STRAND      197    199       {ECO:0000244|PDB:4R68}.
FT   HELIX       201    203       {ECO:0000244|PDB:4JNK}.
FT   HELIX       211    214       {ECO:0000244|PDB:4JNK}.
FT   TURN        216    219       {ECO:0000244|PDB:4JNK}.
FT   STRAND      220    222       {ECO:0000244|PDB:1I10}.
FT   HELIX       228    245       {ECO:0000244|PDB:4JNK}.
FT   HELIX       250    264       {ECO:0000244|PDB:4JNK}.
FT   STRAND      269    276       {ECO:0000244|PDB:4JNK}.
FT   STRAND      288    296       {ECO:0000244|PDB:4JNK}.
FT   STRAND      299    304       {ECO:0000244|PDB:4JNK}.
FT   HELIX       310    327       {ECO:0000244|PDB:4JNK}.
SQ   SEQUENCE   332 AA;  36689 MW;  401E8604CEB7F908 CRC64;
     MATLKDQLIY NLLKEEQTPQ NKITVVGVGA VGMACAISIL MKDLADELAL VDVIEDKLKG
     EMMDLQHGSL FLRTPKIVSG KDYNVTANSK LVIITAGARQ QEGESRLNLV QRNVNIFKFI
     IPNVVKYSPN CKLLIVSNPV DILTYVAWKI SGFPKNRVIG SGCNLDSARF RYLMGERLGV
     HPLSCHGWVL GEHGDSSVPV WSGMNVAGVS LKTLHPDLGT DKDKEQWKEV HKQVVESAYE
     VIKLKGYTSW AIGLSVADLA ESIMKNLRRV HPVSTMIKGL YGIKDDVFLS VPCILGQNGI
     SDLVKVTLTS EEEARLKKSA DTLWGIQKEL QF
//
